Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688108'
s ROE % Range Over the Past 10 Years
Min: -18.3 Med: 3.67 Max: 16.34
Current: 7.5
During the past 10 years, Sino Medical Sciences Technology's highest ROE % was 16.34%. The lowest was -18.30%. And the median was 3.67%.
SHSE:688108's ROE % is ranked better than 66.17% of 798
companies
in the Medical Devices & Instruments industry
Industry Median: 2.51
vs SHSE:688108: 7.50
Sino Medical Sciences Technology (SHSE:688108) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Sino Medical Sciences Technology ROE % Related Terms
Sino Medical Sciences Technology ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sino Medical Sciences Technology's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Medical Sciences Technology ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sino Medical Sciences Technology's ROE % distribution charts can be found below:
* The bar in red indicates where Sino Medical Sciences Technology's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Sino Medical Sciences Technology (SHSE:688108) has a ROE % of 10.20% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sino Medical Sciences Technology and its competitors. This is 178% above median its historical median of 3.67. According to the industry distribution chart, Sino Medical Sciences Technology ranks #270 out of 798 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is Sino Medical Sciences Technology's ROE % too high?
Sino Medical Sciences Technology's current ROE % of 10.20% is 178% above median its 10-year median of 3.67. The Medical Devices & Instruments industry median ROE % is 2.51. Sino Medical Sciences Technology's value of 10.20% is 306.4% above this industry median. Based on the distribution chart, Sino Medical Sciences Technology ranks #270 out of 798 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sino Medical Sciences Technology has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sino Medical Sciences Technology's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sino Medical Sciences Technology ranks #270 out of 798 companies for ROE %. This puts Sino Medical Sciences Technology in the upper half of its industry. The industry median ROE % is 2.51. Sino Medical Sciences Technology's value of 10.20% is 306.4% above this benchmark. While the company's 10-year median is 3.67 vs. the industry median of 2.51, Sino Medical Sciences Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.51, based on 798 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Medical Sciences Technology's current ROE % of 10.20% is 306.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sino Medical Sciences Technology and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Medical Sciences Technology's current ROE % is 10.20%, which is 178% above median its own 10-year median of 3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Medical Sciences Technology stock overvalued right now?
Based on GuruFocus' analysis, Sino Medical Sciences Technology (SHSE:688108) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.42, compared to a current price of ¥15.18 — trading 25.7% below its estimated fair value. The current ROE % is 10.20%, which is 178% above median its 10-year median of 3.67 and 306.4% above the Medical Devices & Instruments industry median of 2.51. Sino Medical Sciences Technology's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Sino Medical Sciences Technology (SHSE:688108), the current ROE % is 10.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Medical Sciences Technology (SHSE:688108) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Medical Sciences Technology stock appears to be undervalued.
The current stock price of ¥15.18 is trading 25.7% below its estimated GF Value™ of ¥20.42.
GuruFocus considers Sino Medical Sciences Technology to be Modestly Undervalued.
Key valuation signals for SHSE:688108:
ROE %: 10.20% (178% above median its 10-year median of 3.67)
GF Value™: ¥20.42 vs. price of ¥15.18 (25.7% below fair value)
Industry Position: 306.4% above the Medical Devices & Instruments median (#270 of 798)
No single metric tells the full story. See the SHSE:688108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Medical Sciences Technology Business Description
Sino Medical Sciences Technology Inc is a China based company engaged in the research, development, production and sales of high-end interventional medical devices.
80GF Score
Get the complete analysis for SHSE:688108
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688108 has been successfully added to your 
